Enzymes for reduced immunological stress
View Patent ↗Compositions suitable for oral administration to an animal comprising at least one immune stress-reducing enzyme in an amount effective to decrease the level of positive acute phase protein in an animal, increase the level of negative acute phase protein in an animal, and/or improve animal growth performance is provided, as are methods using such compositions. The compositions include animal feed compositions, liquid compositions other than animal feed, and solid compositions other than animal feed.
1. A composition suitable for oral administration to an animal comprising an immune stress-reducing enzyme in an orally acceptable carrier, wherein said composition is selected from the group consisting of:
(i) an animal/feed comprising at least 20 IU of said immune stress-reducing enzyme/kg feed;
(ii) a liquid composition other than an animal feed comprising at least 40,000 IU of said immune stress-reducing enzyme/L; and
(iii) a solid composition other than an animal feed comprising at least 40,000 IU of said immune stress-reducing enzyme/kg,
wherein said immune stress-reducing enzyme is selected from the group consisting of α-1,6-mannosidase, α-1,2-mannosidase, α-1,3-mannosidase, and endo-α-1,6-D-mannanase.
2. The composition of claim 1 , wherein said composition is an animal feed comprising at least 20 of said immune stress-reducing enzyme/kg feed.
3. The composition of claim 1 , wherein said composition is a liquid composition other than an animal feed comprising at least 40,000:EU of said immune stress-reducing enzyme/L.
4. The composition of claim 1 , wherein said composition is a solid composition other than an animal feed comprising at least 40,000 IU of said immune stress-reducing enzyme/kg.
5. The composition of claim 1 , wherein the composition is a solid composition other than an animal feed comprising at least 80,000 TU of said immune stress-reducing enzyme/kg.
6. The composition of claim 1 , wherein the composition is a solid composition other than an animal feed comprising at least 160,000 IU of said immune stress-reducing enzyme/kg.
7. The composition of claim 1 , wherein the composition is an animal feed that comprises an ingredient that induces an immune response in the animal and wherein said immune stress-reducing enzyme degrades said ingredient.
8. The composition of claim 7 , wherein said ingredient is a non-pathogenic molecule that displays a molecular pattern that is recognized by the animal's innate immune system, and that is degraded by said immune stress reducing enzyme.
9. The composition of claim 7 , wherein said ingredient is an antigen displayed by a pathogenic microorganism.
10. A method of improving animal growth performance and/or reducing immune stress in an animal, comprising orally administering to said animal a composition according to claim 1 .
11. The method of claim 10 , wherein said animal is administered an ingredient that induces an immune response in the animal and wherein said immune stress reducing enzyme degrades said ingredient.
12. The method of claim 11 , wherein said ingredient and said immune stress-reducing enzyme are administered in the same composition.
13. The method of claim 12 , wherein said composition is an animal feed.
14. The method of claim 11 , wherein said ingredient is a non-pathogenic molecule that displays a molecular pattern that is recognized by the animal's innate immune system, and that is degraded by said immune stress reducing enzyme.
15. The method of claim 11 , wherein said ingredient is an antigen displayed by a pathogenic microorganism.
16. A method of preventing or treating infection associated with a pathogenic microorganism that displays an antigen, comprising orally administering to an animal in need thereof a composition according to claim 1 , wherein said immune stress-reducing enzyme degrades said antigen.